Professional Summary
Professional Overview
Ted Daley is the Co-founder and Chief Executive Officer of Selva Therapeutics, a biotechnology company focused on developing innovative treatments for rare and complex diseases. With over 15 years of industry experience, he brings a wealth of expertise in business development, strategic planning, and driving operational excellence within the biopharmaceutical sector.
Experience Summary
Current Role
As the Co-founder and CEO of Selva Therapeutics, Ted is responsible for setting the strategic vision, leading the company's growth initiatives, and overseeing all operational aspects. Under his leadership, Selva has established a robust pipeline of promising drug candidates and forged strategic partnerships with leading research institutions and pharmaceutical companies.
Ted's entrepreneurial acumen and deep understanding of the industry have been instrumental in positioning Selva as a disruptive force in the field of rare disease treatment. He has successfully secured significant funding to support the company's research and development efforts, and has built a highly talented and dedicated team to execute on Selva's ambitious goals.
Career Progression
Prior to co-founding Selva Therapeutics, Ted served as the President and Chief Business Officer at Raptor Pharmaceuticals, where he played a pivotal role in the company's growth and eventual acquisition. He has also held the position of Entrepreneur in Residence at the University of California, San Diego, where he provided guidance and mentorship to aspiring biotech entrepreneurs.
Additionally, Ted has served on the Board of Directors for Empire Biotechnologies and currently sits on the Board of Endure Biotherapeutics, demonstrating his deep involvement and influence within the biotechnology industry.
Academic Background
Ted holds a Bachelor of Science degree in Biochemistry from the University of California, San Diego, where he graduated with honors. His strong academic foundation and passion for scientific research have been instrumental in shaping his successful career in the biotechnology sector.
Areas of Expertise
- Business development and strategic partnerships
- Operational management and optimization
- Rare disease drug development
- Fundraising and investor relations
- Regulatory affairs and clinical trial oversight
- Talent acquisition and team building
Professional Impact
Throughout his career, Ted has been recognized for his exceptional leadership and his ability to drive innovation within the biotechnology industry. He has led the successful development and commercialization of several rare disease treatments, and his work has had a tangible impact on the lives of patients and their families.
Ted's contributions extend beyond his direct business achievements, as he is also an active mentor and advocate for the next generation of biotech entrepreneurs. His deep industry knowledge, strategic vision, and commitment to advancing the field of rare disease research have made him a respected and influential figure within the biotechnology community.
Conclusion
With his extensive industry experience, proven entrepreneurial track record, and unwavering dedication to improving patient outcomes, Ted Daley is well-positioned to lead Selva Therapeutics to new heights. As the company continues to grow and make strides in the development of innovative rare disease treatments, Ted's strategic guidance and operational expertise will be instrumental in driving long-term success and making a meaningful impact on the lives of those affected by these complex conditions.
